Oil above $80 lifts stocks, offsets trade and bond market chill
LONDON (Reuters) – European shares rose and Wall Street was set for a stronger open on Tuesday, as oil above $80 a barrel lifted energy shares, despite worries around the…
The night a Chinese billionaire was accused of rape in Minnesota
MINNEAPOLIS/NEW YORK (Reuters) – With the Chinese billionaire Richard Liu at her Minneapolis area apartment, a 21-year-old University of Minnesota student sent a WeChat message to a friend in the…
White House optimistic on China trade; no date for more talks
WASHINGTON (Reuters) – The United States is optimistic about finding a way forward in its trade dispute with China, but it does not have a date scheduled for further talks…
Diabetes drugs less affordable, less available in lower income countries
(Reuters Health) – People who live in low-income and middle-income countries may have a harder time finding and affording essential medicines for diabetes than residents of wealthier nations, a recent…
EU approves fifth copy of AbbVie’s $18 billion drug Humira
LONDON (Reuters) – Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription medicine – ramping up competition among makers of less-expensive biotech…
AstraZeneca plots China robot offensive to counter price cuts
WUXI, China/LONDON (Reuters) – With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca (AZN.L) aims to move from simply…
Headwinds before takeoff for new Thai Airways team
BANGKOK (Reuters) – Struggling national carrier Thai Airways International PCL is pinning hopes of a revival to its 1990s heyday on a new leadership team, jet purchases and improving its…
Global shares knocked after new U.S. tariff threat on Chinese goods
LONDON (Reuters) – European share markets followed Asian counterparts lower on Monday as investors took fright at news Washington was set to announce a new round of tariffs on Chinese…
Trump ‘likely’ to announce new China tariffs as early as Monday: source
WASHINGTON (Reuters) – U.S. President Donald Trump is likely to announce new tariffs on about $200 billion on Chinese imports as early as Monday, a senior administration official told Reuters…
U.S. regulator approves Teva migraine drug, shares rise
(Reuters) – Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved the company’s new…